The California Stem Cell Report
Subscribe
Sign in
Home
CIRM Sustainability
CIRM Future
CIRM's $3.9 Billion Priority …
A CIRM Primer -- A to Z
About
cirm future
Latest
Top
Discussions
California's $23 Billion Research Answer to Trump Cuts Resurfaces with More Support
Ballot approval next fall would be needed.
Jan 21
•
David Jensen
What to Do with $207 Million? Finance Training or Finance Research to Develop Revolutionary Cures and Therapies?
CIRM's own financial survival is at stake with voters
Nov 17, 2025
•
David Jensen
2
Bubble Baby Saga Hits Another Milestone; 95 Percent, Long-term Success Rate Reported
Good news for UCLA and CIRM, but agency receives little mention
Oct 16, 2025
•
David Jensen
3
1
$23 Billion California Research Funding Update: CIRM Eyeing the Proposal and Its Future Role
Measure proposed to deal with Trump cuts, but could make CIRM redundant
Oct 10, 2025
•
David Jensen
2
California's Stem Cell/Gene Therapy Program Comes Under Sharp Fire From Scientists
Letter says research nixed at $12 billion program without considering scientific merit
Sep 24, 2025
•
David Jensen
1
The Selling of CIRM: California's Stem Cell/Gene Therapy Program Seeks to Build Hope, Trust and 'Awe'
New multi-year, PR campaign could be key when CIRM's research billions run out
Sep 17, 2025
•
David Jensen
3
2
1
The latest in the Prasad/FDA Saga, Not to Mention Millions from California and Capricor
A Duchenne muscular dystrophy cell treatment is at stake
Aug 10, 2025
•
David Jensen
1
National Research Funding Turmoil and California's Stem Cell Agency's Sustainability
Comments from the CIRM chair, Vito Imbasciani
Jun 30, 2025
•
David Jensen
1
Waning Financial Enthusiasm for Gene Therapies: National Picture is Bleak, Says Barron's
California multibillion-dollar program scheduled to discuss its research portfolio next week
Jun 19, 2025
•
David Jensen
1
Fertile Field for California's Stem Cell/Gene Therapy Story: Can It Measure Up?
National turmoil over research in sharp contrast to operations of California Institute for Regenerative Medicine
May 8, 2025
•
David Jensen
1
From Market Studies to 'Value' Messaging, California Stem Cell/Gene Therapy Agency Bets Big on Affordability Plan
Far-reaching effort to ensure that revolutionary treatments reach all patients
May 1, 2025
•
David Jensen
3
California's Affordability Plan for Cell/Gene Therapy Could be National Model
CIRM proposal nears launch in two clinical award rounds totaling $295 million
Apr 28, 2025
•
David Jensen
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts